Lanzhou Foci Pharmaceutical News

Foci Pharmaceuticals (002644): Short-term performance is under pressure and waiting for the implementation of a new strategy

Apr 10 00:00

Foci Pharmaceutical (002644): OTC price increase for branded traditional Chinese medicines accelerates market development in South China

Mar 18 00:00

Foci Pharmaceutical (002644): Q3 net profit is under short-term pressure, and the company has entered a new stage of development

Nov 9, 2023 00:00

Foci Pharmaceutical (002644): Gansu SDIC officially enters the company to begin a new stage of growth

Sep 16, 2023 00:00

Foci Pharmaceutical (002644): Polishing Longyao's Gold Sign, Optimizing Treatment, Releasing Inner Vitality

長城證券Jun 8, 2023 00:00

Foci Pharmaceuticals (002644): Foreign Investment Rating (FIR)

中盛在線Jan 10, 2020 00:00

Commentary on the incident at Foci Pharmaceutical (002644): Higher prices across the product line led to an increase in gross margin

西南證券Mar 5, 2018 00:00

Commentary on the Foci Pharmaceutical (002644) Incident: Piloting Traditional Chinese Medicine Formulation Particles Opens New Room for Growth

西南證券Feb 22, 2018 00:00

Comments on the annual report of Forts Pharmaceutical (002644): continue to sell and promote investment in high revenue growth for the whole year

西南證券Feb 13, 2018 00:00

Fots Pharmaceutical (002644) dynamic tracking report: quarterly revenue growth accelerates the company's operating inflection point

西南證券Jan 26, 2018 00:00

Foci Pharmaceutical (002644) Quarterly report comment: the construction of the plant in the new area is progressing smoothly and continue to strengthen the marketing work.

招商證券Oct 24, 2017 00:00

Forts Pharmaceutical (002644) Quarterly report comments: sales expenses continue to be optimistic about the company's long-term prospects

西南證券Oct 23, 2017 00:00

Comments on Foci Pharmaceutical (002644): strengthen Marketing before the release of New production capacity for the Rapid growth of traditional Chinese Medicine Business

招商證券Jul 30, 2017 00:00

Foci Pharmaceutical (002644) medium report comments: the performance is in line with expectations and the new factory will be put into production soon.

華創證券Jul 27, 2017 00:00

Fots Pharmaceutical (002644) report comments: the increase in sales investment in a single quarter leads to a slowdown in the growth of net profit

西南證券Jul 26, 2017 00:00

佛慈制药(002644)半年报点评：单季度销售投入增加 导致净利润增速放缓

西南證券Jul 26, 2017 00:00

佛慈制药(002644)年报点评：营销优势改善毛利率水平 阿胶、六味大单品放量驱动业绩恢复性增长

國海證券Mar 21, 2017 00:00

佛慈制药(002644)年报点评：业绩保持平稳增长 期待新厂区投产

華創證券Mar 21, 2017 00:00

佛慈制药(002644)年报点评：毛利率持续提升 迎来收入恢复性增长

招商證券Mar 17, 2017 00:00

佛慈制药(002644)年报点评：收入结构持续优化 盈利水平逐渐提升

西南證券Mar 17, 2017 00:00